Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled versus systemic corticosteroids for acute exacerbation of chronic obstructive pulmonary disease
ChiCTR-IPR-17011390Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Jun 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of budesonide and methylprednisolone sodium succinate in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoint: Microbial. Planned start Jun 2017; status: not yet recruiting.
02
Drugs
budesonidemethylprednisolone sodium succinate
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ChiCTR-IPR-17011390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17011390.